Inverness Medical Innovations Acquires Alere Medical
WALTHAM, Mass., Nov. 19 / -- Inverness Medical Innovations, Inc. (AMEX:IMA) today announced the completion of its acquisition of Alere Medical, Inc. at a purchase price of $302 million, comprising approximately $128 million in cash and $174 million in Inverness common stock and assumed options. Alere, headquartered in Reno, Nevada, provides health and care management services and programs to healthcare organizations in helping patients with chronic illnesses manage their conditions.
About Inverness
By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For additional information on Inverness Medical Innovations, please visit www.invernessmedical.com.
FCMN Contact: leydberk@tiac.net
Source: Inverness Medical Innovations
CONTACT:
Doug Guarino
Director of Corporate Relations of Inverness
Medical Innovations
+1-781-647-3900
or
Joe Cummings
Manager of Marketing and Communications of Alere Medical, Inc.
+1-775-336-1146
Web site: www.invernessmedical.com/